Home / Market News / $EHTH
benzinga Corporate Catalyst Impact 65/100 ● negative

eHealth Q2 EPS $(1.18), Inline, Sales $33.600M Beat $33.286M Estimate

Aug 4, 2026, 8:21 PM UTC · Primary ticker $EHTH

eHealth reported Q2 earnings per share that met analyst expectations, but sales, while beating estimates, saw a substantial year-over-year decline. The mixed results suggest ongoing challenges for the company despite outperforming revenue forecasts slightly.

eHealth (EHTH) announced Q2 earnings where its loss per share of $(1.18) was in line with analyst consensus, indicating no major surprise on the bottom line. However, while sales of $33.600 million beat the consensus estimate of $33.286 million, this represents a significant 44.72% decrease from the same period last year. This substantial revenue decline, despite the slight beat on estimates, suggests underlying business challenges that could impact investor sentiment. For traders, the short-term implication is a potentially neutral to slightly negative reaction as the inline EPS is offset by the large year-over-year sales drop, raising questions about the company's growth trajectory and long-term prospects.

$EHTH neutral Q2 EPS inline, sales beat estimates but declined significantly
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.